{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:00:23Z","timestamp":1758355223496,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"DOI":"10.7759\/cureus.92700","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:13:22Z","timestamp":1758280402000},"source":"Crossref","is-referenced-by-count":0,"title":["From Purines to Plaques: Serum Uric Acid as a Cardiometabolic Marker and Its Correlation With Dyslipidemia in Essential Hypertension"],"prefix":"10.7759","author":[{"given":"Anbalagan","family":"Suyambulingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abinaya","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Jayakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebby Perin","family":"Mathisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig DI","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008, 359:1811-21. 10.1056\/NEJMra0800885","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali M","year":"2001","unstructured":"Mazzali M, Hughes J, Kim YG, et al.. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001, 38:1101-6. 10.1161\/hy1101.092839","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302535","article-title":"The role of uric acid in the pathogenesis of human cardiovascular disease","volume":"99","author":"Kanbay M","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013, 99:759-66. 10.1136\/heartjnl-2012-302535","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2014.75","article-title":"Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension","volume":"37","author":"Kuwabara M","year":"2014","unstructured":"Kuwabara M, Niwa K, Nishi Y, et al.. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res. 2014, 37:785-9. 10.1038\/hr.2014.75","journal-title":"Hypertens Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.07.026","article-title":"High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects","volume":"37","author":"Cicero AF","year":"2017","unstructured":"Cicero AF, Rosticci M, Fogacci F, Grandi E, D'Addato S, Borghi C. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects. Eur J Intern Med. 2017, 37:38-42. 10.1016\/j.ejim.2016.07.026","journal-title":"Eur J Intern Med"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1991.03470210076036","article-title":"Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration","volume":"266","author":"Facchini F","year":"1991","unstructured":"Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991, 266:3008-11.","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1595","article-title":"Obesity and the metabolic syndrome in developing countries","volume":"93","author":"Misra A","year":"2008","unstructured":"Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93:S9-30. 10.1210\/jc.2008-1595","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi HK","year":"2007","unstructured":"Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007, 120:442-7. 10.1016\/j.amjmed.2006.06.040","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald WT","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18:499-502. 10.1093\/clinchem\/18.6.499","journal-title":"Clin Chem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","unstructured":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285.2486-97. 10.1001\/jama.285.19.2486","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00600.2006","article-title":"Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress","volume":"293","author":"Sautin YY","year":"2007","unstructured":"Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress. Am J Physiol Cell Physiol. 2007, 293:C584-96. 10.1152\/ajpcell.00600.2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig DI","year":"2008","unstructured":"Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008, 300:924-32. 10.1001\/jama.300.8.924","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson PC","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011, 63:102-10. 10.1002\/acr.20344","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000701","article-title":"Serum uric acid and the risk of cardiovascular and renal disease","volume":"33","author":"Borghi C","year":"2015","unstructured":"Borghi C, Rosei EA, Bardin T, et al.. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015, 33:1729-41. 10.1097\/HJH.0000000000000701","journal-title":"J Hypertens"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10370","article-title":"Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study","volume":"71","author":"Kuwabara M","year":"2018","unstructured":"Kuwabara M, Hisatome I, Niwa K, et al.. Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study. Hypertension. 2018, 71:78-86. 10.1161\/HYPERTENSIONAHA.117.10370","journal-title":"Hypertension"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/414989-from-purines-to-plaques-serum-uric-acid-as-a-cardiometabolic-marker-and-its-correlation-with-dyslipidemia-in-essential-hypertension","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:13:24Z","timestamp":1758280404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/414989-from-purines-to-plaques-serum-uric-acid-as-a-cardiometabolic-marker-and-its-correlation-with-dyslipidemia-in-essential-hypertension"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.92700","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}